Sample | Title | Value | Rank |
GSM1256958 | SLE-patients; Group 1: CD4 T lymphocytes; active SLE 2 | 765.731 | 95 |
GSM1256959 | SLE-patients; Group 1: CD4 T lymphocytes; active SLE 4 | 1108.9 | 97 |
GSM1256960 | SLE-patients; Group 1: CD4 T lymphocytes; active SLE 7 | 762.606 | 95 |
GSM1256961 | SLE-patients; Group 1: CD4 T lymphocytes; active SLE 8 | 598.268 | 94 |
GSM1256962 | SLE-patients; Group 1: CD4 T lymphocytes; active SLE 9 | 601.834 | 94 |
GSM1256963 | SLE-patients; Group 1: CD4 T lymphocytes; active SLE 12 | 580.302 | 94 |
GSM1256972 | Yellow fever vaccinated NDs; Group 4: CD4 T lymphocytes; ND 54 before YFV | 626.964 | 94 |
GSM1256976 | Yellow fever vaccinated NDs; Group 5: CD4 T lymphocytes; ND 54 seven days after YFV | 633.999 | 94 |
GSM1256973 | Yellow fever vaccinated NDs; Group 4: CD4 T lymphocytes; ND 55 before YFV | 625.223 | 95 |
GSM1256977 | Yellow fever vaccinated NDs; Group 5: CD4 T lymphocytes; ND 55 seven days after YFV | 668.463 | 95 |
GSM1256974 | Yellow fever vaccinated NDs; Group 4: CD4 T lymphocytes; ND 56 before YFV | 599.064 | 94 |
GSM1256978 | Yellow fever vaccinated NDs; Group 5: CD4 T lymphocytes; ND 56 seven days after YFV | 585.06 | 94 |
GSM1256975 | Yellow fever vaccinated NDs; Group 4: CD4 T lymphocytes; ND 57 before YFV | 682.697 | 95 |
GSM1256979 | Yellow fever vaccinated NDs; Group 5: CD4 T lymphocytes; ND 57 seven days after YFV | 602.44 | 94 |